Home > SANTE - SCIENCES DE LA VIE > Industrie Pharmaceutique > Exelixis Inc: Premium Company ...
AUTRES RESSOURCES
 
AUTRES SECTEURS
 
TOUS NOS SECTEURS
 
Industrie Pharmaceutique > Etude de marché sectorielle
 Exelixis Inc: Premium Company Profile
€ 396,00
Editeur :
Datamonitor
Langue :
Anglais
Date de publication :
Décembre 2007
Taille du document :
58
Autres informations :
Description , Table des matières
 

Recevez cette publication aujourd'hui !
Plus d'information ?
+33 437 37 1637
 
Documents Publics
1,200,000 documents
Téléchargement illimités
 
Etudes Privées
50,000 rapports et études
Paiement à la piéce
 
1.Télécharger nos rapports publics

Accés complet à plus de 1,2 Million de documents publics : études de marché, statistiques sectorielles, fiches pays, monographie d'entreprises, veille concurentielle, rapports annuels...

Nos documents publics sur le même théme (5)
Oncology market in France
162 pages | Septembre 2006 | Anglais
 
 
   
Main focus: cancer
Research focus: market definition,market outlook,
Geographic focus: france,canada,finland,switzerland,norway,sweden,...
   
Oncology market in France
162 pages | Octobre 2006 | Anglais
 
 
   
Main focus: cancer
Research focus: market definition,market outlook,
Geographic focus: france,canada,switzerland,finland,mauritius,usa,...
   
Oncology market in USA
92 pages | Février 2008 | Anglais
 
 
   
Main focus: cancer,oncology,lymphoma,breast cancer,...,...
Research focus: market size and estimates,market definition,
Geographic focus: usa,france,germany,united kingdom,switzerland,...
   
Oncology market in USA
456 pages | Mai 1999 | Anglais
 
 
   
Main focus: cancer,breast cancer,lung cancer,health care,...
Research focus: market outlook,market definition,demand analysis,
Geographic focus: usa,india
   
Oncology market in Canada
74 pages | Janvier 2002 | Anglais
 
 
   
Main focus: cancer,breast cancer,prostate cancer,lung cancer,...,...
Research focus: market definition,market outlook
Geographic focus: canada,france,australia
   
Autres recherches sur le même thème
Rechercher d'autres rapports publics à télécharger
 
 
 
2. Rechercher d'autres rapports et études à commander

Rechercher et commander ici parmi 50.000 études de marché publiées par les principaux instituts d'études internationaux


Rapports privés en relation
Pharmaceutical Packaging Market
80 pages | Avril 2002 |
This report will enable you to:Analyse the size of the UK market for pharmaceutical packaging between 1997 and 2006, by type: - cartons - containers - labels and leaflets - blister & strip p
1 479,00 €
 
 
OTC Cough and Cold Remedies in Germany
15 pages | Juillet 2002 |
The German market for OTC cough and cold remedies reached a value of Euro 972 million (US$ 918 million) in 2001, up 0.4% on the previous year.
During the review period, the market grew by 9.4%, an
198,00 €
 
 
The Pharmaceutical Distribution Outlook 1998-2008
165 pages | Octobre 1998 |
Industry growth and consolidation means that pharmaceutical manufacturers are no longer geographically limited in their operations and now market their products globally, creating a vast commercia
795,00 €
 
 
Pharmaceutical Pricing Strategies 2000: Entering the new millennium
240 pages | Juin 2000 |
The favorable climate of the pharmaceutical sector has changed radically over the past ten years.
Where once a company's freedom over pricing decisions was almost limitless, external pressure
955,00 €
 
 
Healthcare In Scotland
52 pages | Mai 2000 |
The Scottish Presentation Includes:- The Structure Of The NHS In Scotland- The Funding Of The NHS In Scotland- Distribution Of The NHS Budget In Scotland- Segmentation Of Expenditure - Total Capital E
327,00 €
 
 
The Pharmaceutical Profitability Outlook
150 pages | Février 1999 |
Is pharmaceutical profitability sustainable into the 21st century? “As the pharmaceutical industry finds itself at a crossroads, the strategic directions companies take will be pivotal in determini
795,00 €
 
 
The Generics Outlook 2001
242 pages | Février 2001 |
“By the year 2004, it is expected that the value of the total western European generics sector may have risen to $19 billion, representing almost 15% of allpharmaceuticals.
In the USA, the val
955,00 €
 
 
The Pharmaceutical Mergers and Acquisitions Outlook 2001
128 pages | Octobre 2001 |
Pharmaceutical companies have recently undertaken extensive M&A activity to either build critical mass, create organic growth or through strategic alliances to build virtual mass.
The Pharmaceu
1 200,00 €
 
 
Healthcare In Wales
50 pages | Mai 2000 |
The Welsh Presentation Includes:- The Structure Of The NHS In Wales- Revenue Expenditure On Health Services In Wales- Number Of Hospital Units - Number Of Available Inpatient Beds- Number Of Occupied
327,00 €
 
 
Pharmaceutical Pricing Strategies
121 pages | Juillet 1998 |
Which pricing strategies will enable your company to maximise profitability? As healthcare cost-containment intensifies and pricing freedom is eroded, the need to develop new strategies to mainta
795,00 €
 
 
 
Autres secteurs en relation
Rechercher d'autres rapports!
 
 
 
Présentation de l'étude de marché - Description & Table des matières
 Exelixis Inc: Premium Company Profile

Introduction

Exelixis is a development-stage biotechnology company dedicated to the discovery and development of small molecule therapeutics for the treatment of cancer and other serious diseases. The company has a fully integrated drug discovery platform to fuel the growth of its development pipeline, which is primarily focused on cancer.

Scope

  • Contains corporate strategy, value chain presence and SWOT Analysis
  • Provides detailed business description, segment analysis, 5-year financial trends, key products and key competitors
  • Includes information on suppliers/ partners, shareholding structure and key employees with biographies


  • Highlights

    Exelixis is experienced in discovering and developing therapeutics for cancer and renal diseases. The company has in-house and collaborative pipeline products and currently has no marketed products.

    The company derives its revenues from contract, licensing and collaboration. During 2002-2006, the company's total revenues grew at a CAGR of 22% from $44 million in 2002 to $99 million in 2006.

    During the period 2006-2010, licensing, collaboration and other revenues are forecasted to grow from $99 million to $301 million. Licensing, collaboration and others would remain to be the sole revenue contributor as the company does not have any launch product or expect to launch over the period 2006-2010.

    Reasons to Purchase

  • Access all the important information and analysis on the company in a single report
  • Understand company's strengths, weaknesses, opportunities and threats along with business strategy and value chain
  • Gain access to company's adjusted five year financial data along with key ratios and market capitalization


  •  

    TABLE OF CONTENTS
    Overview 1
    Catalyst 1
    Summary 1
    Company Structure 6
    Company Overview and Key Facts 6
    Business Description 7
    History 10
    Locations and Subsidiaries 15
    Company Financials 16
    Stock Market Performance 16
    P&L 18
    Balance Sheet 21
    Cash Flow 21
    Business Segment Performance 22
    Products & Services 23
    Pipeline Products 23
    AC Forecast Product Sales 28
    Competitors and Strategic Business Relationships 29
    Key Competitors 29
    Key Suppliers 29
    Key Clients 29
    Shareholding Structure 30
    Strategy 31
    Company View 31
    Corporate Strategy 34
    SWOT Analysis 37
    Overview 37
    Strengths 38
    Weaknesses 40
    Opportunities 41
    Threats 42
    Value Chain Analysis 43
    Discovery and Product Development 43
    Scorecard 45
    Overview 45
    Scorecard Analysis 46
    Key Employees 47
    Key Employee Biographies 48
    Financial and Operational Overview 56
    Financial and Operational Overview 56
    APPENDIX 58
    Ask the analyst 58
    Datamonitor consulting 58
    Disclaimer 58


    TABLE OF FIGURES
    Figure 1: Exelixis - Operating Revenue/Cost Analysis, 2002-2006 ($ Mn) 19


    TABLE OF TABLES
    Table 1: Exelixis - Key Facts 6
    Table 2: Exelixis - Locations and Subsidiaries 15
    Table 3: Exelixis - Year-End Share Price and Market Capitalization, 2002-2006 ($) 16
    Table 4: Exelixis - Key Events Impacting Share Price Performance 17
    Table 5: Exelixis - Operating Revenue/Cost Analysis, 2002-2006 ($ Mn) 18
    Table 6: Exelixis - Operating Cost Ratio Analysis, 2002-2006 (% of total revenues) 20
    Table 7: Exelixis - Balance Sheet, 2002-2006 ($ Mn) 21
    Table 8: Exelixis - Cash Flow, 2002-2006 ($ Mn) 21
    Table 9: Exelixis - Revenue Breakdown by Division, 2002-2006 ($ Mn) 22
    Table 10: Exelixis - In-house Pipeline Products 23
    Table 11: Exelixis - Collaboration Products 25
    Table 12: Exelixis - Forecast Sales, 2006-2010 ($ Mn) 28
    Table 13: Exelixis - Key Competitors 29
    Table 14: Exelixis - Key Clients 29
    Table 15: Exelixis - Key Shareholders 30
    Table 16: Exelixis - SWOT Analysis Summary 37
    Table 17: Exelixis - Value Chain Analysis 43
    Table 18: Exelixis - Scorecard 45
    Table 19: Exelixis - Key Employees 47
    Table 20: Exelixis - Financial and Operational Overview 56



    New Search:

    PPLSEN